Morbidity and mortality of candidaemia in Europe: an epidemiologic meta-analysis-Reference-Cited by-同舟云学术

Morbidity and mortality of candidaemia in Europe: an epidemiologic meta-analysis

Published:2019-10 Issue:10 Volume:25 Page:1200-1212
ISSN:1198-743X
Container-title:Clinical Microbiology and Infection
language:en
Short-container-title:Clinical Microbiology and Infection

Author:

Koehler P.,Stecher M.,Cornely O.A.,Koehler D.,Vehreschild M.J.G.T.,Bohlius J.,Wisplinghoff H.,Vehreschild J.J.

Funder

German Center for Infection Research

Miltenyi Biotec GmbH

Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases

University of Cologne

Actelion

Amplyx

Arsanis

Astellas

AstraZeneca

Basilea

Bayer

Cidara

Da Volterra

F2G

Gilead

GSK

anssen Pharmaceuticals

Leeds University

Matinas

Medicines Company

MedPace

Melinta Therapeutics

Menarini Ricerche

Merck/MSD

Miltenyi

Paratek Pharmaceuticals

Pfizer

PSI

Rempex

Roche

Sanofi Pasteur

Scynexis

Seres Therapeutics

Summit

Tetraphase

Vical

IQVIA

Innovative Medicines Initiative Joint

European Union’s Seventh Framework Programme

EFPIA companies’

Astellas Pharma

DaVolterra

Gilead Sciences

MaaT Pharma

Morphochem

Organobalance

Uniklinik Freiburg/Kongress und Kommunikation

Beckmann

BioMerieux

Bruker Daltonics

Cepheid

Hologic

r-biopharm

Siemens

SepcificTechnologies

Deutsches Zentrum für Infektionsforschung

Uniklinik Freiburg / Kongress und Kommunikation

Akademie für Infektionsmedizin

Universität Manchester, Deutsche Gesellschaft für Infektiologie

Ärztekammer Nordrhein

Uniklinik Aachen

Back Bay Strategies

Deutsche Gesellschaft für Innere Medizin

Bundesministerium für Bildung und Forschung

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference154 articles.

1. ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients;Cornely;Clin Microbiol Infect,2012

2. ESCMID* guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures;Cuenca-Estrella;Clin Microbiol Infect,2012

3. Candidemia in the intensive care unit: analysis of direct treatment costs and clinical outcome in patients treated with echinocandins or fluconazole;Heimann;Eur J Clin Microbiol Infect Dis,2015

4. Attributable costs of patients with candidemia and potential implications of polymerase chain reaction-based pathogen detection on antifungal therapy in patients with sepsis;Bloos;J Crit Care,2013

5. Excess mortality, length of stay and cost attributable to candidaemia;Hassan;J Infect,2009

Cited by 190 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reducing candidaemia risk in urology patients: Revised algorithm & Pharmacist-Led Implementation;Infection, Disease & Health;2024-11

2. Attributable mortality of candidemia – Results from the ECMM Candida III multinational European Observational Cohort Study;Journal of Infection;2024-09

3. Clinical Characteristics of Candidemia Due to Candida parapsilosis with Serial Episodes: Insights from 5-Year Data Collection at a Tertiary Hospital in Korea;Journal of Fungi;2024-09-01

4. Nosocomial transmission of fluconazole-resistant Candida glabrata bloodstream isolates revealed by whole-genome sequencing;Microbiology Spectrum;2024-08-20

5. Mapping of the Lipid-Binding Regions of the Antifungal Protein NFAP2 by Exploiting Model Membranes;Journal of Chemical Information and Modeling;2024-08-16